Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | WNT1 | P04628 | 2/20 | 0.30 |
| ▸ | GSK3B | P49841 | 2/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.30 |
| ▸ | CLK2 | P49760 | 1/20 | 0.30 |
| ▸ | CLK3 | P49761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23048750 | 0.82 | ABL1 (0.33) | ACACBACACAABL1WNT1GSK3B | |
| SCHEMBL23048634 | 0.72 | TTK (0.33) | ACACBACACAABL1WNT1GSK3B | |
| SCHEMBL23740771 | 0.72 | DYRK1A (0.36) | ACACBACACAABL1WNT1GSK3B | |
| SCHEMBL23048670 | 0.72 | DYRK1A (0.31) | ACACBACACAWNT1GSK3BDYRK1A | |
| SCHEMBL23048823 | 0.71 | NNMT (0.34) | ACACBACACAABL1WNT1GSK3B | |
| SCHEMBL23048847 | 0.70 | HCAR3 (0.33) | ACACBACACAABL1WNT1GSK3B | |
| SCHEMBL4404906 | 0.70 | HCAR3 (0.44) | ACACBACACAABL1WNT1GSK3B | |
| SCHEMBL23916312 | 0.69 | ACACB (0.35) | ACACBACACAABL1WNT1GSK3B | |
| SCHEMBL23740976 | 0.67 | HCAR3 (0.33) | ACACBACACAABL1WNT1GSK3B | |
| SCHEMBL24219443 | 0.66 | ACACB (0.35) | ACACBACACAABL1WNT1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3448386-B1 | ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF | SAMUMED LLC (US) | 2021-03-03 | — | — | EP | disclosed |